Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
to drive forward projects related to improving immunotherapies for cancer within the Department of Medicine, Division of Oncology, and Section of Computational Biology. The Foltz lab works at
-
website to find further information about our values and Orion as an employer https://www.orion.fi/en/careers/orion-as-an-employer/. Our expectations To be a successful, ideally you should have the
-
Research Assistant B (Center for Cellular Immunotherapy) Job Profile Title Clinical Research Assistant B Job Description Summary The Center for Cellular Immunotherapies (CCI) drives scientific innovation in
-
University of California, San Francisco | San Francisco, California | United States | about 2 months ago
are not limited to apheresis, chemotherapy, biotherapy, immunotherapy, blood transfusions, hydration and electrolyte therapy, injections and blood draws, enzymes and iron infusions, and antibiotics
-
of microbiome-driven immunotherapies in personalized settings”whose responsible person is D. Luis Francisco Lorenzo Martín; through the recruitment system provided for in the FICUS Staff Recruitment Manual
-
, bacteriophage therapy, and the role of microbiota in cancer biology and response to chemotherapy or immunotherapy. We are particularly seeking investigators who use innovative approaches to understand the nature
-
leukapheresis for cancer immunotherapy. Our Radiology Department is one of the most advanced and comprehensive veterinary imaging centers in the country. Equipment of note includes PET/CT, digital 3T MRI, equine
-
top scientists A variety of other research centers and institutes to develop collaborative research, including the Brown Center for Immunotherapy and the Center for Computational Biology and
-
toxicities and side-effect management across various cancer therapies (e.g., chemotherapy, immunotherapy, radiation). Skilled in counseling patients and families on prognosis, goals of care, and advance care
-
organoid (PTGO) models to test immunotherapy strategies. The ultimate goal is to: 1) identify conserved myeloid phenotypes across tumours; 2) determine which are associated with favourable clinical outcomes